1030377-80-0 Usage
General Description
The chemical compound "(R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone" is a complex molecule with multiple functional groups, including a benzoxazole, a triazole, and a diazepan. It is a chiral compound, indicated by the (R)- prefix, meaning that it has a specific orientation in space. The compound has potential applications in pharmaceuticals, as it contains structural elements commonly found in drug molecules. Its multiple functional groups also make it of interest in the field of chemical synthesis and medicinal chemistry, as it may be able to interact with a variety of biological targets. Further research on this compound could uncover its potential uses in drug development and other areas of science.
Check Digit Verification of cas no
The CAS Registry Mumber 1030377-80-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,0,3,7 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1030377-80:
(9*1)+(8*0)+(7*3)+(6*0)+(5*3)+(4*7)+(3*7)+(2*8)+(1*0)=110
110 % 10 = 0
So 1030377-80-0 is a valid CAS Registry Number.
1030377-80-0Relevant articles and documents
Identification, synthesis and strategy for minimization of potential impurities in the synthesis of suvorexant
Lv, Xunlei,Pan, Jing,Liu, Weiyuan,Meng, Xue,Chen, Liang,Zhou, Ting,Lin, Kuaile,Ye, Deyong,Zhou, Weicheng
, p. 2225 - 2236 (2021)
Eight process-related impurities in the synthesis of suvorexant were identified, while six of them were described for the first time. In order to get the references for the process optimization and quality control of API, the eight compounds were synthesized. According to the possible formation pathways, a modified synthesis and the strategy for impurity control in the corresponding reactions were established.